Are you Dr. Mobashery?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
50 Pequot Ave
Ms 6025-B3125
New London, CT 06320Phone+1 860-732-1033
Summary
- Dr. Niloufar Mobashery, MD is an infectious disease specialist in New London, Connecticut. She is currently licensed to practice medicine in Pennsylvania and California.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 2002 - 2004
University of MarylandResidency, Internal Medicine, 1999 - 2002
Weill Cornell MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2002 - 2026
PA State Medical License 2008 - 2014
Publications & Presentations
PubMed
- 28 citationsGlecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open...Lai Wei, Guiqiang Wang, Negar N. Alami, Wen Xie, Jeong Heo
The Lancet. Gastroenterology & Hepatology. 2020-09-01 - 1 citationsOmbitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II).Tarik Asselah, Negar N. Alami, Christophe Moreno, Stanislas Pol, Stylianos Karatapanis
Health Science Reports. 2019-03-01 - 2 citationsPharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese Patients.Jiuhong Zha, Bifeng Ding, Haoyu Wang, Weihan Zhao, Chen Yu
European Journal of Drug Metabolism and Pharmacokinetics. 2019-02-01
